Surveyed Global Life Science Teams Expend Up To $30 Million in 2017 for Patient Adherence Activities

RESEARCH TRIANGLE PARK, NC—(Marketwired – June 14, 2017) – As increasing patient adherence efforts continue an upward trend in the pharmaceutical and healthcare industry, surveyed global life science firms report expanding patient adherence budgets in 2017, according new research by business intelligence firm Cutting Edge Information.

Data published in the study, Patient Adherence Program Planning: Drive Compliance to Improve Treatment Outcomes, revealed that a Top 10 pharma company reported the largest budget increase, growing from $10 million in 2015 to $30 million in 2017.

Additional data from same study found that smaller pharmaceutical companies surveyed report significantly smaller budgets. However, one Top 50 company and two small medical device companies expect budget increases in coming years.

“Patient adherence has been a growing interest within the life sciences industry for several years,” said Adam Bianchi, senior director of research at Cutting Edge Information. “To support these continuing — and in many cases, growing — patient–centered efforts, life science companies are increasing monetary resources to their marketed brands.”

Compared to their global counterparts, surveyed regional groups typically report much smaller budgets. According to the study, two of five teams report stable brand budgets from 2014 to 2017, including one Top 50 company, whose team reports a small growth from 2014 ($2 million) to 2015 ($2.1 million). Another small pharmaceutical company's team reports a brand budget of $500,000 across all four years.

One Top 50 company's regional team is an exception to the smaller regional budget trend; it reports the largest brand budget across all four years. The company reports a $35 million brand adherence budget for 2014, which is higher than the budget reported by the Top 10 company's global team mentioned before. However, this regional team's budget decreased by $20 million in the next year to only $15 million. The budget is expected to continue declining to only $10 million in 2017.

Patient Adherence Program Planning: Drive Compliance to Improve Treatment Outcomes, available at https://www.cuttingedgeinfo.com/product/patient–adherence–program–planning/, examines how pharmaceutical, biotechnology and other life science companies develop and support patient adherence topics. The report includes detailed benchmarking metrics and case studies of winning initiatives, including budgets, timing, outsourcing and vendor selection, as well as program channels — including digital and mobile resources — for new patient adherence initiatives.

The report is a decision support tool for life science companies seeking to implement or improve their approaches to patient adherence. The report is designed to help executives:

  • Develop a winning combination of patient adherence activities across a range of media
  • Take advantage of new patient adherence technologies and strategies, such as gamification
  • Benchmark budget and staffing resources for patient adherence initiatives
  • Discover industry trends and insights into new approaches for patient adherence programs

For more information about Cutting Edge Information's patient adherence research and to obtain a copy of Patient Adherence Program Planning: Drive Compliance to Improve Treatment Outcomes, please visit https://www.cuttingedgeinfo.com.

Image Available: http://www.marketwire.com/library/MwGo/2017/6/12/11G140927/Images/June_14_2017_–_PH226_–_Surveyed_Global_Life_Scienc–78f49fa1e42cb3dea53cf74081e3c83e.jpg
Image Available: http://www.marketwire.com/library/MwGo/2017/6/12/11G140927/Images/June_14_2017_–_PH226_–_Surveyed_Global_Life_Scienc–09052f61f34abed19bf034a3371535ae.jpg

MediaValet Announces Grant of Options

VANCOUVER, BC—(Marketwired – June 14, 2017) – MediaValet Inc. (TSX VENTURE: MVP) (the “Company”) announced today that it has issued 550,000 stock options to certain employees and directors of the Company. The options are being offered in conformance with TSX Venture Exchange regulations as incentive compensation. The options have a term of five years and an exercise price of $0.09 per share.

Following the issuance, the Company has 7,890,664 incentive stock options outstanding. As approved at the June 16, 2016 annual general meeting, the Company's Stock Option Plan allows the Board to issue the equivalent of up to 10% of the issued and outstanding share capital of the Company on a rolling basis.

About MediaValet, Inc.

MediaValet stands at the forefront of the cloud–based digital asset management industry. Built exclusively on Microsoft Azure and available on 34 highly secure and hyper scalable data centers around the world, MediaValet is uniquely equipped to meet the digital asset management needs of any organization, no matter its size, its industry or its location. Cutting–edge technology, exceptional product design, and unlimited friendly customer service are at the core of MediaValet's DNA — ensuring exceptional customer and user experiences are delivered at all times. Learn more at www.mediavalet.com.

Follow MediaValet: Blog, Twitter and LinkedIn

“Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.”

CIBM Bank Announces Promotions to Executive Vice President

CHAMPAIGN, IL—(Marketwired – June 14, 2017) – Today, CIBM Bank announced the promotion of four employees to Executive Vice President, including: Mr. Mark Wilmington – EVP & Director of Retail Banking, based in Peoria, Illinois; James Mullaney – EVP & Director of Corporate Banking, based in Wheaton, Illinois; Mr. Gary Maughan – EVP & Mortgage Banking Director, based in Naperville, Illinois; and Ms. Joanne Blaesing – EVP & Director of Community Development, based in Waukesha, Wisconsin.

Mr. Brian Chaffin, President and CEO of CIBM Bank stated, “Each of these individuals have made significant contributions to our organization and each manage a critically important aspect of our business while reflecting the values of our organization as described in our motto of Service, Solutions and Integrity. Their promotions are a recognition of the work they have done, and continue to do each day toward moving our company forward and meeting our goals.”

CIBM Bank is a wholly owned subsidiary of CIB Marine Bancshares, Inc. (OTCQB: CIBH) that operates as “Marine Bank” in its Indiana and Wisconsin markets, “Central Illinois Bank” in its central Illinois market, and “Avenue Bank” in its Chicagoland market. The Avenue Mortgage division, located in Naperville, Illinois, serves all CIBM Bank markets. Equal Housing Lender, Member FDIC.

UEX Corporation Reports Results of Annual General Shareholder Meeting

VANCOUVER, BC—(Marketwired – June 14, 2017) – UEX Corporation (TSX: UEX) (“UEX” or the “Company”) reports the results of its Annual General Meeting of Shareholders (the “AGM” or the “Meeting”) held on June 13, 2017 in Vancouver, B.C.

Shareholders voted in favour of all items of business, including the election of each director nominee. A total of 109,892,565 votes were cast representing 35.90% of the issued common shares as of the record date for the Meeting, as follows:

         
Directors   Tabulation of Votes in Favour   Tabulation of Votes Withheld
Suraj P. Ahuja   107,550,232   (97.87%)   2,342,333   (2.13%)
Mark P. Eaton   107,540,757   (97.88%)   2,334,308   (2.12%)
Roger Lemaitre   109,525,665   (99.67%)   366,900   (0.33%)
Emmet McGrath   106,791,765   (97.18%)   3,100,800   (2.82%)
Catherine Stretch   108,813,837   (99.02%)   1,078,728   (0.98%)
Graham C. Thody   108,738,037   (98.95%)   1,154,528   (1.05%)

KPMG LLP was re–appointed as auditor of the Company.

The Company also announced that the Shareholders approved the renewal of the Company's stock option plan for a further three–year period at the Meeting.

At the Board of Directors meeting following the AGM, Mr. Graham Thody was re–appointed Chairman of the Board, Mr. Suraj Ahuja was re–appointed as Lead Director and Mr. Roger Lemaitre was re–appointed President, Chief Executive Officer and interim Chief Financial Officer.

On behalf of the Board of Directors of UEX

“Roger Lemaitre”

Roger Lemaitre
President & CEO
UEX Corporation
Phone: 604–669–2349
Website: www.uex–corporation.com